BDBM508808 US11071721, Example 52::US11071721, Example 53::US11607396, Example 53

SMILES FC(F)[C@H]1CCN1C(=O)c1nc2[C@@H](F)C[C@@H](c3ccccc3)n2n1

InChI Key InChIKey=KZGHWYVQBNEEFB-UHFFFAOYSA-N

Data  3 KI

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 3 hits for monomerid = 508808   

LigandPNGBDBM508808(US11071721, Example 53 | US11071721, Example 52 | ...)
Affinity DataKi:  5nMAssay Description:The ability of the receptor interacting protein kinase (RIPK1) to catalyze the hydrolysis of adenosine-5′-triphosphate (ATP) is monitored using...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/7/2022
Entry Details
US Patent

LigandPNGBDBM508808(US11071721, Example 53 | US11071721, Example 52 | ...)
Affinity DataKi:  9nMAssay Description:The ability of the receptor interacting protein kinase (RIPK1) to catalyze the hydrolysis of adenosine-5′-triphosphate (ATP) is monitored using...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/5/2023
Entry Details
US Patent

LigandPNGBDBM508808(US11071721, Example 53 | US11071721, Example 52 | ...)
Affinity DataKi:  9nMAssay Description:The ability of the receptor interacting protein kinase (RIPK1) to catalyze the hydrolysis of adenosine-5′-triphosphate (ATP) is monitored using...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/7/2022
Entry Details
US Patent